JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoque, N.
Right arrow Articles by Karmazyn, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoque, N.
Right arrow Articles by Karmazyn, M.

Vol. 294, Issue 2, 770-777, August 2000

Inhibition of alpha 1-Adrenergic-Mediated Responses in Rat Ventricular Myocytes by Adenosine A1 Receptor Activation: Role of the KATP Channel1

Nina Hoque, Michael A. Cook and Morris Karmazyn

Department of Pharmacology and Toxicology, University of Western Ontario, London, Ontario, Canada

Both beta - and alpha 1-adrenoceptors mediate the myocardial effects of catecholamines. It is well known that adenosine inhibits beta -dependent effects; however, whether alpha 1-dependent responses can be similarly modulated is unclear. Accordingly, rat ventricular myocytes were exposed for 25 min to the alpha 1 agonist phenylephrine (2 µM, in the presence of 1 µM propranolol) in the absence or presence of adenosine (100 µM) or the A1 receptor-selective agonist N6-cyclopentyladenosine (CPA, 1 µM). We also investigated the effects of KATP blockade with glibenclamide (1 µM), the protein kinase C inhibitor bisindolylmaleimide (20 nM), and pertussis toxin (300 ng/ml), which uncouples Gi protein/receptor interaction, and assessed whether effects of adenosine were mimicked by KATP activation with either pinacidil or cromakalim (5 µM). Phenylephrine significantly increased cell shortening by 190% and the Ca2+ transient by 24%, which was abolished by either adenosine or CPA, but not in the presence of the A1 receptor-selective antagonist 8-cyclopentyl-1,3-dipropylxanthine (1 µM), and was abolished by pertussis toxin. The effect of adenosine or CPA was reversed by glibenclamide and mimicked by either cromakalim or pinacidil. Bisindolylmaleimide was without effect. The A2 or A3 receptor agonists 2-(4-(2-carboxyethyl)phenylethylamino)-5'-N-ethylcarboxamidoadenosine and N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide (1 µM each), respectively, were without effect. Neither CPA nor adenosine modulated the effect of endothelin-1 (5 nM), which also acts via the phosphoinositide hydrolysis pathway. We conclude that adenosine selectively inhibits alpha 1-adrenergic-mediated effects in rat ventricular myocytes through a Gi protein-dependent mechanism involving A1 receptor and KATP activation. Our study further suggests that endogenous adenosine may modulate alpha 1-mediated effects of catecholamines.


1 This work was supported by a grant (MT-12123) from the Medical Research Council of Canada. M.K. is a Career Investigator of the Heart and Stroke Foundation of Ontario.


0022-3565/00/2942-0770$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. K. Snabaitis, R. D'Mello, S. Dashnyam, and M. Avkiran
A Novel Role for Protein Phosphatase 2A in Receptor-mediated Regulation of the Cardiac Sarcolemmal Na+/H+ Exchanger NHE1
J. Biol. Chem., July 21, 2006; 281(29): 20252 - 20262.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X. T. Gan, V. Rajapurohitam, J. V. Haist, P. Chidiac, M. A. Cook, and M. Karmazyn
Inhibition of Phenylephrine-Induced Cardiomyocyte Hypertrophy by Activation of Multiple Adenosine Receptor Subtypes
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 27 - 34.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Avkiran and R. S Haworth
Regulatory effects of G protein-coupled receptors on cardiac sarcolemmal Na+/H+ exchanger activity: signalling and significance
Cardiovasc Res, March 15, 2003; 57(4): 942 - 952.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Varani, R. Manfredini, V. Iannotta, C. Pancaldi, E. Cattabriga, C. Uluoglu, P. A. Borea, and F. Portaluppi
Effects of Doxazosin and Propranolol on A2A Adenosine Receptors in Essential Hypertension
Hypertension, December 1, 2002; 40(6): 909 - 913.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Chen, X. T. Gan, J. V. Haist, Q. Feng, X. Lu, S. Chakrabarti, and M. Karmazyn
Attenuation of Compensatory Right Ventricular Hypertrophy and Heart Failure following Monocrotaline-Induced Pulmonary Vascular Injury by the Na+-H+ Exchange Inhibitor Cariporide
J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 469 - 476.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
T. Reffelmann, E. C. Skobel, H. Kammermeier, P. Hanrath, and E. R. Schwarz
Activation of ATP-Sensitive Potassium Channels in Hypoxic Cardiac Failure Is not Mediated by Adenosine-1 Receptors in the Isolated Rat Heart
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2001; 6(2): 189 - 200.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.